RWR | VNQ | RWR / VNQ | |
Gain YTD | 1.128 | 5.034 | 22% |
Net Assets | 1.83B | 63.8B | 3% |
Total Expense Ratio | 0.25 | 0.13 | 192% |
Turnover | 4.00 | 7.00 | 57% |
Yield | 3.93 | 3.89 | 101% |
Fund Existence | 24 years | 21 years | - |
RWR | VNQ | |
---|---|---|
RSI ODDS (%) | N/A | 3 days ago86% |
Stochastic ODDS (%) | 3 days ago79% | 3 days ago80% |
Momentum ODDS (%) | 3 days ago89% | 3 days ago90% |
MACD ODDS (%) | 3 days ago85% | 3 days ago89% |
TrendWeek ODDS (%) | 3 days ago87% | 3 days ago87% |
TrendMonth ODDS (%) | 3 days ago86% | 3 days ago86% |
Advances ODDS (%) | 5 days ago85% | 5 days ago86% |
Declines ODDS (%) | 3 days ago84% | 20 days ago84% |
BollingerBands ODDS (%) | 3 days ago84% | 3 days ago82% |
Aroon ODDS (%) | 4 days ago81% | 3 days ago84% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ASVRX | 9.84 | 0.07 | +0.72% |
American Century Small Cap Value R | |||
VTSMX | 152.62 | 0.67 | +0.44% |
Vanguard Total Stock Mkt Idx Inv | |||
GSLLX | 23.27 | 0.09 | +0.39% |
Goldman Sachs Enhanced U.S. Equity Inv | |||
PDIAX | 22.54 | 0.07 | +0.31% |
Virtus KAR Equity Income A | |||
FIJYX | 31.04 | N/A | N/A |
Fidelity Advisor Biotechnology Z |
A.I.dvisor indicates that over the last year, RWR has been closely correlated with UDR. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if RWR jumps, then UDR could also see price increases.
A.I.dvisor indicates that over the last year, VNQ has been closely correlated with ARE. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if VNQ jumps, then ARE could also see price increases.